These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2915165)
1. The case for patient access to experimental therapy. Delaney M J Infect Dis; 1989 Mar; 159(3):416-9. PubMed ID: 2915165 [No Abstract] [Full Text] [Related]
2. Public access to experimental drug therapy: AIDS raises yet another conflict between freedom of the individual and welfare of the individual and public. Richman DD J Infect Dis; 1989 Mar; 159(3):412-5. PubMed ID: 2915164 [No Abstract] [Full Text] [Related]
3. Trial of experimental AIDS drug to be continued, with revisions. Kolata G N Y Times Web; 1990 Mar; ():A1, A15. PubMed ID: 11646750 [No Abstract] [Full Text] [Related]
4. AIDS and the FDA: an ethical case for limiting patient access to new medical therapies. Shorr AF IRB; 1992; 14(4):1-5. PubMed ID: 11651391 [No Abstract] [Full Text] [Related]
5. Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials. Annas GJ Villanova Law Rev; 1989 Sep; 34(5):771-97. PubMed ID: 11651162 [No Abstract] [Full Text] [Related]
7. Regulation of drug treatments for HIV and AIDS: a contractarian model of access. Salbu SR Yale J Regul; 1994; 11(2):401-53. PubMed ID: 11660141 [No Abstract] [Full Text] [Related]
8. Making experimental drugs available for AIDS treatment. Krim M AIDS Public Policy J; 1987; 2(2):1-5. PubMed ID: 11650026 [No Abstract] [Full Text] [Related]
9. Getting new drugs to people with AIDS: a public policy response to Lansdale. Cohen MN Hastings Constit Law Q; 1991; 18(3):471-85. PubMed ID: 11651493 [No Abstract] [Full Text] [Related]
10. May a human subject waive the right to be treated as a human subject? Novick A AIDS Public Policy J; 1990; 5(1):45-8. PubMed ID: 11650389 [No Abstract] [Full Text] [Related]
11. Controlled clinical trials of AIDS drugs: the best hope. Cooper EC JAMA; 1989 Apr; 261(16):2445. PubMed ID: 2649701 [No Abstract] [Full Text] [Related]
12. Treating the troops. Howe EG; Martin ED Hastings Cent Rep; 1991; 21(2):21-4; discussion 24-9. PubMed ID: 2045278 [No Abstract] [Full Text] [Related]
13. The need for improved access to experimental drug therapy: AIDS activists and their call for a parallel track policy. Terrizzi L Adm Law J; 1991; 4(3):589-634. PubMed ID: 11659598 [No Abstract] [Full Text] [Related]
14. FDA puts the brakes on xenotransplants. Nowak R Science; 1995 May; 268(5211):630-1. PubMed ID: 7732365 [No Abstract] [Full Text] [Related]
15. AIDS: due process, equal protection, and the right to treatment. Spece RG Issues Law Med; 1988; 4(3):283-344. PubMed ID: 3069801 [No Abstract] [Full Text] [Related]
16. Innovative therapy. The responsibility of hospitals. Cowan DH; Bertsch E J Leg Med; 1984 Jun; 5(2):219-51. PubMed ID: 6611383 [No Abstract] [Full Text] [Related]
17. An analysis of the relationship between human experimentation and drug discovery in the United States. DeFelice SL Drug Metab Rev; 1974; 3(1):167-84. PubMed ID: 4609707 [No Abstract] [Full Text] [Related]
18. Nonvalidated therapies and HIV disease. McGill/Boston Research Group. Freedman B Hastings Cent Rep; 1989; 19(3):14-20. PubMed ID: 2656580 [TBL] [Abstract][Full Text] [Related]
19. Protectionism and the new research imperative in pediatric AIDS. Ackerman TF IRB; 1990; 12(5):1-5. PubMed ID: 11654001 [No Abstract] [Full Text] [Related]
20. Twice wrong on AIDS. Gieringer D N Y Times Web; 1987 Jan; ():A21. PubMed ID: 11646161 [No Abstract] [Full Text] [Related] [Next] [New Search]